Last cycle's warning on HIMS resolved exactly as flagged: its +20.07% weekly pop reversed to -14.67% this cycle, and its trailing year deepened further, from -23.16% to -34.63%, with alpha1y worsening from -44.97 to -54.5. SBUX is the one clean upgrade — its regime flipped from basing to uptrend, the first structural change in that direction this book has shown. TSLA's repair story, the headline out of the last scan, has stalled rather than continued: its trailing year fell from +13.35% to a nearly flat +0.8%, and it now sits further below its 200-day than before.

Data as-of the 2026-08-28 close for all eight names — no staleness this cycle. The comparison baseline below is the August 22 scan.

HIMS is the cleanest confirmation in this cycle's data that the trailing-year check called it right last time. Its 7-day return, the strongest in the book last cycle at +20.07%, flipped to -14.67% this cycle — the hot week did not carry forward. Its trailing year, already flagged as the weakest counter-argument in the book, deepened further: down 34.63% from 23.16%, with alpha1y worsening from -44.97 to -54.5. There's no ambiguity left in this name's read: the week was noise on top of a trend that's still getting worse, not better.

SBUX is the one genuine upgrade this cycle. Its regime flipped from basing to uptrend — the first structural change in that direction this book has carried — as its RSI ticked up to 55.4 and its trailing year improved slightly to +22.53% from +20.91%, with price now 11% above its 200-day. This is the steadiest name in the book getting steadier, not a reversal story.

TSLA's repair narrative, the headline out of the last scan, stalled rather than continued. Its RSI cooled to 50.9 from 58.0, and while its 30-day return actually improved to +16.9% from -2.98%, the more important numbers moved the wrong way: its trailing year fell sharply to a nearly flat +0.8% from +13.35%, and its distance below its 200-day widened to -13% from roughly -10%. TSLA's thesis is still rated intact in the underlying data and its regime held at downtrend rather than downgrading further, but the annual trend that was improving last cycle isn't improving this cycle — worth tracking closely rather than assuming the earlier repair is still in progress.

The rest of the book is largely unchanged in character. BRBR bounced technically — RSI up to 44.0 from 35.3 — but its thesis remains explicitly rated broken, and its trailing year (-73.84%) and alpha1y (-93.72) are both still catastrophic; a 9-point RSI bounce doesn't move that needle. NKE (-49.18% trailing year, -23.9% below its 200-day) and LULU (-41.09%, -21.6% below its 200-day) both remain weak on every window, unchanged from last cycle's read. CROX's RSI ticked up slightly to 41.0 from 38.6 but stays the low point among the genuinely intact names — it's still up 41.65% over the trailing year and 19.5% above its 200-day, so its low RSI continues to read as a pullback inside a strong trend rather than a breakdown. DPZ's regime held at downtrend, and its trailing year remains negative at -22.04%, consistent with last cycle's read that the tag was the accurate one all along.

• HIMS: 7-day flipped from +20.07% to -14.67%, reversing last cycle's headline move; trailing year widened to -34.63% (was -23.16%); alpha1y worsened to -54.5 (was -44.97).
• SBUX: regime upgraded basing → uptrend, the first structural upgrade this book has shown; RSI 55.0 → 55.4; trailing year improved to +22.53% (was +20.91%).
• TSLA: RSI 58.0 → 50.9; trailing year fell sharply to +0.8% (was +13.35%); distance below its 200-day widened to -13% (was roughly -10%); regime held at downtrend, thesis still rated intact.
• BRBR: RSI 35.3 → 44.0, a technical bounce; thesis remains rated broken; trailing year still -73.84%.
• DPZ: RSI 51.3 → 54.9; regime held downtrend; trailing year still negative at -22.04%.
• CROX: RSI 38.6 → 41.0; still +41.65% over the trailing year and above its 200-day.
• NKE: RSI 46.0 → 43.5, roughly flat; regime held collapse; trailing year widened slightly to -49.18% (was -46.5%).
• LULU: RSI held essentially flat at 51.9 (was 51.9); trailing year widened slightly to -41.09% (was -38.91%).

Regime labels describe chart structure, not a buy/sell call, and this cycle is a clean example of the trailing-year check working in both directions. HIMS's hot week from last cycle reversed exactly as the annual data implied it should — the mismatch didn't linger. SBUX's upgrade is a genuine structural change backed by improving numbers at every horizon, not a short-window artifact. TSLA is the more nuanced case this cycle: its thesis rating and regime tag haven't moved, but the trailing year underneath both weakened materially, which argues for treating the "repair" framing from last scan with more caution going forward rather than assuming it's still in progress. BRBR, NKE, LULU, and DPZ are unchanged in character — weak on every window that matters, with BRBR carrying the only explicitly broken thesis in the book.

Tier A — Genuinely intact, positive trailing year (2): SBUX (fresh upgrade), CROX (low RSI, but +41.65% on the year).

Tier B — Repair stalled or uncertain (2): TSLA (thesis intact, but trailing year weakened sharply), DPZ (regime steady but negative on every window).

Tier C — Weak on every horizon (4): HIMS (hot week reversed as warned), BRBR (thesis broken), NKE (fresh collapse tag agrees with the year), LULU (unchanged negative read).

None of the eight names reads as a clean fresh entry this cycle. SBUX is the one name with a genuine structural upgrade behind it. CROX's low RSI continues to sit on top of a strong trailing year, worth a second look once the technical picture stabilizes. TSLA's earlier repair narrative needs to show up again in the trailing-year number before it's worth revisiting. BRBR's thesis stays rated broken.

• Tape data (price/RSI/SMA/returns/1-year, SMA200): full-scan pre-computed summaries as of the 2026-08-28 close — cultural-thesis.